OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
FORA$2.1559

Forian Inc.

Advanced Medical Equipment & TechnologyVerified

Forian Inc. has a market capitalization of $63.42 million and a price-to-book ratio of 2.13, indicating a premium valuation relative to its book value. The company's liquidity position is strong, with a current ratio of 2.97, suggesting it can comfortably meet its short-term obligations. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The company's profitability metrics are concerning, with a negative return on equity of -9.65% and a return on assets of -6.51%, both significantly below industry norms. Operating income was -$3.76 million, and net income was -$2.87 million, reflecting ongoing operational challenges. Gross profit of $16.10 million was insufficient to offset operating expenses, contributing to the net loss. Forian Inc. generates revenue from its healthcare equipment and technology solutions, though the financial data does not provide a breakdown of revenue by segment or geographic region. The company's revenue for the latest period was $30.26 million, but the outlook for future growth is not specified in the available data. The company's free cash flow was negative at -$2.67 million, indicating that it is not generating sufficient cash from operations to fund its capital expenditures and other obligations. Analysts have assigned a mean price target of $2.10, which is slightly below the current market price of $2.15, suggesting a neutral outlook. The mean recommendation of 3.00 (on a scale from 1 to 5) further supports a neutral stance, with no strong buy or buy ratings. There are no immediate filing-based liquidity or dilution flags, and the risk assessment indicates low liquidity and dilution risks. The company's capital structure is currently free of dilution pressures, with no near-term dilution expected. The absence of long-term debt and the strong current ratio suggest that the company is in a stable financial position. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's operating cash flow of $2.89 million provides some cushion, but it is not enough to offset the negative free cash flow. The company's total assets of $44.13 million and total equity of $29.78 million suggest a solid asset base, but the negative returns on equity and assets highlight the need for operational improvements.

30-day price · FORA+0.09 (+4.4%)
Low$2.04High$2.20Close$2.15As of10 May, 00:00 UTC
Profile
CompanyForian Inc.
TickerFORA.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Forian Inc. provides healthcare equipment and technology solutions, primarily serving the medical industry.

Classification. Forian Inc. is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a classification confidence of 0.92.

Forian Inc. has a market capitalization of $63.42 million and a price-to-book ratio of 2.13, indicating a premium valuation relative to its book value. The company's liquidity position is strong, with a current ratio of 2.97, suggesting it can comfortably meet its short-term obligations. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The company's profitability metrics are concerning, with a negative return on equity of -9.65% and a return on assets of -6.51%, both significantly below industry norms. Operating income was -$3.76 million, and net income was -$2.87 million, reflecting ongoing operational challenges. Gross profit of $16.10 million was insufficient to offset operating expenses, contributing to the net loss. Forian Inc. generates revenue from its healthcare equipment and technology solutions, though the financial data does not provide a breakdown of revenue by segment or geographic region. The company's revenue for the latest period was $30.26 million, but the outlook for future growth is not specified in the available data. The company's free cash flow was negative at -$2.67 million, indicating that it is not generating sufficient cash from operations to fund its capital expenditures and other obligations. Analysts have assigned a mean price target of $2.10, which is slightly below the current market price of $2.15, suggesting a neutral outlook. The mean recommendation of 3.00 (on a scale from 1 to 5) further supports a neutral stance, with no strong buy or buy ratings. There are no immediate filing-based liquidity or dilution flags, and the risk assessment indicates low liquidity and dilution risks. The company's capital structure is currently free of dilution pressures, with no near-term dilution expected. The absence of long-term debt and the strong current ratio suggest that the company is in a stable financial position. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's operating cash flow of $2.89 million provides some cushion, but it is not enough to offset the negative free cash flow. The company's total assets of $44.13 million and total equity of $29.78 million suggest a solid asset base, but the negative returns on equity and assets highlight the need for operational improvements.
Key takeaways
  • Forian Inc. has a strong liquidity position with a current ratio of 2.97 and no long-term debt.
  • The company is currently unprofitable, with a negative return on equity of -9.65% and a net loss of $2.87 million.
  • Analysts have a neutral outlook, with a mean price target of $2.10 and a mean recommendation of 3.00.
  • The company's free cash flow is negative at -$2.67 million, indicating cash flow challenges.
  • There are no immediate liquidity or dilution risks, and the company's capital structure is conservative.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$30.3M
Gross profit$16.1M
Operating income-$3.8M
Net income-$2.9M
R&D
SG&A
D&A
SBC
Operating cash flow$2.9M
CapEx
Free cash flow-$2.7M
Total assets$44.1M
Total liabilities$14.4M
Total equity$29.8M
Cash & equivalents
Long-term debt$0.00
Valuation
Market price$2.15
Market cap$63.4M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B2.1
P/Tangible book2.1
Tangible book$29.8M
Net cash
Current ratio3.0
Debt/Equity0.0
ROA-6.5%
ROE-9.7%
Cash conversion-1.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricFORAActivity
Op margin-12.4%-16.5% medp25 -174.5% · p75 8.8%above median
Net margin-9.5%-16.5% medp25 -172.4% · p75 8.4%above median
Gross margin53.2%47.4% medp25 34.2% · p75 65.3%above median
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity0.0%4.3% medp25 0.0% · p75 28.0%bottom quartile
Observations
IR observations
Mean price target2.10 USD
Median price target2.10 USD
High price target2.10 USD
Low price target2.10 USD
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.09 USD
Last actual EPS-0.09 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 16:09 UTC#fc6aa5dd
Market quoteclose USD 2.15 · shares 0.03B diluted
no public URL
2026-05-16 16:11 UTC#9b6a9c5a
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 23:24 UTCJob: e9e747b5